Monoclonal Antibody Infusion Treatment to treat patients with COVID-19
Referring physicians should use the links below to access documents outlining the monoclonal antibody infusion treatment screening criteria, as well as the patient referral form.
All patient referral forms should be faxed to 915-577-7245 for scheduling.
Effective April 1, 2021, The Hospitals of Providence will now be the provider in El Paso for the COVID-19 monoclonal antibody infusion treatment. The monoclonal antibody infusion treatment is used for the treatment of mild-to-moderate COVID-19
in adult and pediatric patients and patients qualifying as high-risk of progressing to severe COVID-19, with the goal being to reduce the severity of symptoms and the number of patients requiring a hospital stay. All monoclonal antibody infusion treatments
will take place at The Hospitals of Providence Memorial Campus.
The monoclonal antibody infusion treatment is used in patients who meet the following criteria:
Non-hospitalized adults and adolescents 12 years of age and older
Mild to moderate symptoms
Within 10 days of symptom onset
No current need for supplemental oxygen
Patients who have received a positive test result for COVID-19 should talk with their doctor or healthcare provider to determine if the monoclonal antibody infusion treatment is right for them.